Stay updated with breaking news from Nasdaq Krtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Free Report) has been given an average rating of “Moderate Buy” by the fifteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average […]
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twelve ratings firms that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 1-year target […]
State Board of Administration of Florida Retirement System increased its stake in Karuna Therapeutics, Inc. (NASDAQ:KRTX – Free Report) by 385.5% during the second quarter, according to its most recent filing with the SEC. The fund owned 40,993 shares of the company’s stock after buying an additional 32,550 shares during the quarter. State Board of […]
HC Wainwright reaffirmed their buy rating on shares of Karuna Therapeutics (NASDAQ:KRTX – Free Report) in a research report report published on Monday, Benzinga reports. HC Wainwright currently has a $300.00 price objective on the stock. Several other research analysts have also issued reports on KRTX. JMP Securities reiterated a market outperform rating and issued […]
E Fund Management Co. Ltd. reduced its position in Karuna Therapeutics, Inc. (NASDAQ:KRTX – Free Report) by 9.0% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 1,963 shares of the company’s stock after selling 194 shares during the period. E Fund Management Co. Ltd.’s holdings in Karuna […]